BPC-157

Overview

BPC-157 originates from a protective protein sequence found in human gastric juice, where the parent compound plays a natural role in mucosal defense and repair. The synthetic analog replicates a 15-amino acid sequence and has been studied for its potential to influence fibroblast activity, angiogenesis, nitric oxide pathway regulation, and extracellular matrix remodeling across experimental models.

Its research profile spans multiple biological systems including wound repair, vascular biology, gastrointestinal tissue modeling, connective tissue, and enteric nervous system research.

Chemical Profile

Research Findings

Wound Repair and Tissue Remodeling Research

BPC-157 has been studied for its effects on fibroblast activity, a key process in collagen production and extracellular matrix remodeling. Preclinical models have examined fibroblast migration and proliferation in BPC-157-treated subjects, with observations of wound closure outcomes reported in experimental settings.

Angiogenesis and Vascular Research

Research has examined a proposed “vascular bypass” effect, in which BPC-157 may stimulate collateral blood vessel formation in models of compromised vasculature. Preclinical studies have explored nitric oxide pathway modulation and microcirculation across cardiovascular, gastrointestinal, and musculoskeletal models.

Tendon, Ligament, and Connective Tissue

Due to limited blood supply, tendons and ligaments present significant challenges in repair research. Preclinical models have examined BPC-157’s effects on blood vessel recruitment and fibroblast density in connective tissue, with repair outcome observations reported across ligament, tendon, and soft tissue models.

Gastrointestinal and Enteric Research

As a derivative of a gastric-origin protein, BPC-157 has been studied across gastric ulcer, intestinal permeability, NSAID-induced GI damage, and colitis preclinical models. Research has also examined its role in enteric neuron survival, enteric glial cell activity, gut motility modulation, and gut-brain axis signaling in experimental settings.

Areas of Research

• Wound repair and tissue remodeling research
• Angiogenesis and vascular biology research
• Tendon, ligament, and connective tissue studies
• Gastrointestinal mucosal and barrier research
• Enteric nervous system and gut-brain axis research

Research Use Only: This product is sold exclusively for laboratory and scientific research. It is not approved for human or veterinary use or consumption.

Disclaimer: All products distributed by Resolve Peptides are supplied exclusively for controlled laboratory and scientific research. They are not drugs, supplements, or therapies, and have not been approved by the FDA or any regulatory authority for human or veterinary use. These products are not intended for human or veterinary administration. Regulatory status of research peptides is subject to change; it is the responsibility of the researcher to verify current applicable regulations in their jurisdiction prior to purchase. Any references to biological effects are based solely on experimental and preclinical data.

Referenced Citations

1. Drmic D. et al., Counteraction of perforated cecum lesions in rats with BPC-157, World Journal of Gastroenterology, 2018.
2. Amic F. et al., Bypassing major venous occlusion with BPC-157 therapy, World Journal of Gastroenterology, 2018.
3. Sikiric P. et al., Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract, Current Pharmaceutical Design, 2011.